PrimeRFP SCOUT · Federal Contract Recompete Brief

N6854622F3015Fentanyl nonfentanyl immunoassy reagent — Alere San Diego, Inc

Alere San Diego, Inc holds $42.8M across 9,132 federal awards, concentrated at Department of Defense (DOD). PoP ended Apr 26, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Navy-Marine Corps Public Health Ctr

Awarding office

Alere San Diego, Inc

Recipient

Apr 26, 2022

PoP end

$125K

Obligated

$125K

Potential

325413

NAICS

6550

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Alere San Diego, Inc — $90

Contract facts

Federal

Contract numberN6854622F3015

Also listed asN68546-22-F-3015

Also listed asN6264520D5004-N6854622F3015

AgencyNavy-Marine Corps Public Health Ctr

Awarding officeNavy-Marine Corps Public Health Ctr

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentAlere San Diego, Inc

CAGE6W6P3

UEITWMQTHHN6HM5

NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6550

Parent IDIQ / IDVN6264520D5004

Place of performanceSAN DIEGO CA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startApr 6, 2022

PoP end (current)Apr 26, 2022

Obligated$125K

Current value$125K

Potential value$125K

FENTANYL/NONFENTANYL IMMUNOASSY REAGENT is a federal award for Navy-Marine Corps Public Health Ctr held by Alere San Diego, Inc. Estimated value $125K ($125K obligated). Current period of performance ends Apr 26, 2022. Place of performance: SAN DIEGO CA.

Recompete timing

Public

● Past PoP end (1578 days ago)

Current PoP ended Apr 26, 2022 (1578 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Alere San Diego, Inc — $42.8M obligated across 9,132 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($42.8M) · all agencies · Top 3 shown (3%); remaining ~97% is other agencies.

Department of Defense (DOD)$770K · 2%

Court Services and Offender Supervision Agency (CSOSA)$625K · 1%

Department of Transportation (DOT)$51K · 0%

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract N6854622F3015?

N6854622F3015 (Fentanyl nonfentanyl immunoassy reagent) is a Navy-Marine Corps Public Health Ctr award with a potential value of $125K, currently held by Alere San Diego, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is N68546-22-F-3015?

N68546-22-F-3015 is the dashed form of PIID N6854622F3015 (Fentanyl nonfentanyl immunoassy reagent), held by Alere San Diego, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded N6854622F3015?

Navy-Marine Corps Public Health Ctr awarded N6854622F3015 to Alere San Diego, Inc (potential $125K).

Who is the incumbent on N6854622F3015?

Alere San Diego, Inc is the incumbent with $42.8M across 9132 related awards in SCOUT’s public footprint. The current period of performance ends Apr 26, 2022.

When does Alere San Diego, Inc’s N6854622F3015 come up for recompete?

SCOUT tracks a period-of-performance end of Apr 26, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Apr 6, 2022